Intelligencia AI

Intelligencia AI

Software Development

New York, New York 10,534 followers

Applying machine learning in drug development

About us

Intelligencia uses Artificial Intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We therefore aim to bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster. Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers brings together and interprets disparate data across the life sciences industry. Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning fueled predictions to enable critical decision making. We currently work with several of the largest global pharmaceutical companies and mid-size and smaller biotechnology companies. Diseases will impact nearly every individual. At Intelligencia AI, we work to make a difference.

Website
http://www.intelligencia.ai/
Industry
Software Development
Company size
51-200 employees
Headquarters
New York, New York
Type
Privately Held
Founded
2017
Specialties
Artificial Intelligence, Data Science, Machine Learning, Data Visualization, Experience Design, Healthcare, Pharmaceuticals, Biotechnology, Drug Development, and Clinical Trials

Locations

Employees at Intelligencia AI

Updates

Similar pages

Browse jobs

Funding

Intelligencia AI 3 total rounds

Last Round

Series A

US$ 12.0M

See more info on crunchbase